{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:38:29Z","timestamp":1790242709594,"version":"4.1.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"publisher","award":["SZSM201603029"],"award-info":[{"award-number":["SZSM201603029"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.tube.2021.102091","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T17:05:20Z","timestamp":1621616720000},"page":"102091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["Drug resistance, fitness and compensatory mutations in Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"129","author":[{"given":"Amel Kevin","family":"Alame Emane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0480-0860","authenticated-orcid":false,"given":"Howard E.","family":"Takiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2021.102091_bib1","series-title":"WHO tuberculosis report 2019","author":"WHO","year":"2019"},{"key":"10.1016\/j.tube.2021.102091_bib2","series-title":"WHO tuberculosis report 2020","author":"WHO","year":"2020"},{"key":"10.1016\/j.tube.2021.102091_bib3","series-title":"WHO announces updated definitions of extensively drug-resistant tuberculosis","author":"WHO","year":"2021"},{"key":"10.1016\/j.tube.2021.102091_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S2213-2600(16)30433-7","article-title":"Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study","volume":"5","author":"Dheda","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.tube.2021.102091_bib5","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa1811867","article-title":"A trial of a shorter regimen for rifampin-resistant tuberculosis","volume":"380","author":"Nunn","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tube.2021.102091_bib6","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1164\/rccm.201001-0077OC","article-title":"Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis","volume":"182","author":"Van Deun","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2021.102091_bib7","series-title":"Sustained high rate of successful treatment outcomes: interim results of 75 patients in the Nix-TB clinical study of pretomanid, bedaquiline and linezolid","first-page":"24","author":"Conradie","year":"2018"},{"key":"10.1016\/j.tube.2021.102091_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(17)30079-6","article-title":"The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis","author":"Dheda","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.tube.2021.102091_bib9","first-page":"768","article-title":"Isoniazid susceptibility, catalase activity, and Guinea pig virulence of recently isolated cultures of tubercle bacilli","volume":"73","author":"Wolinsky","year":"1956","journal-title":"Am Rev Tubercul"},{"key":"10.1016\/j.tube.2021.102091_bib10","first-page":"471","article-title":"Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report","volume":"69","author":"Middlebrook","year":"1954","journal-title":"Am Rev Tubercul"},{"key":"10.1016\/j.tube.2021.102091_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2105\/AJPH.45.1.79","article-title":"Public health significance of tubercle bacilli resistant to isoniazid","volume":"45","author":"Widelock","year":"1955","journal-title":"Am J Public Health Nation's Health"},{"key":"10.1016\/j.tube.2021.102091_bib12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/bmj.1.4854.128","article-title":"Tubercle bacilli resistant to isoniazid; virulence and response to treatment with isoniazid in Guinea-pigs","volume":"1","author":"Mitchison","year":"1954","journal-title":"Br Med J"},{"key":"10.1016\/j.tube.2021.102091_bib13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1369-5274(99)00005-3","article-title":"The biological cost of antibiotic resistance","volume":"2","author":"Andersson","year":"1999","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.tube.2021.102091_bib14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1053\/jinf.2000.0711","article-title":"Comparison of fitness of two isolates of Mycobacterium tuberculosis, one of which had developed multi-drug resistance during the course of treatment","volume":"41","author":"Davies","year":"2000","journal-title":"J Infect"},{"key":"10.1016\/j.tube.2021.102091_bib15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1126\/science.118.3063.297","article-title":"Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli","volume":"118","author":"Middlebrook","year":"1953","journal-title":"Science"},{"key":"10.1016\/j.tube.2021.102091_bib16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0272-5231(05)70355-5","article-title":"Genetics of drug resistance in tuberculosis","volume":"18","author":"Telenti","year":"1997","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.tube.2021.102091_bib17","series-title":"Multidrug-resistant tuberculosis","article-title":"The molecular mechanisms of drug resistance in Mycobacterium tuberculosis, p 77-114","author":"Takiff","year":"2000"},{"key":"10.1016\/j.tube.2021.102091_bib18","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/jac\/dku434","article-title":"Comprehensive phenotypic characterization of rifampicin resistance mutations in Salmonella provides insight into the evolution of resistance in Mycobacterium tuberculosis","volume":"70","author":"Brandis","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2021.102091_bib19","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.meegid.2015.03.038","article-title":"Genotypic diversity of multidrug-, quinolone- and extensively drug-resistant Mycobacterium tuberculosis isolates in Thailand","volume":"32","author":"Disratthakit","year":"2015","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.tube.2021.102091_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ng.2878","article-title":"Evolution and transmission of drug-resistant tuberculosis in a Russian population","volume":"46","author":"Casali","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.tube.2021.102091_bib21","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(15)00458-0","article-title":"Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis","volume":"3","author":"Kendall","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.tube.2021.102091_bib22","series-title":"Highly transmitted M. tuberculosis strains are more likely to evolve MDR\/XDR and cause outbreaks, but what makes them highly transmitted? Tuberculosis (Edinb)","author":"Alame Emane","year":"2021"},{"key":"10.1016\/j.tube.2021.102091_bib23","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/infdis\/119.6.678","article-title":"The story of INH","volume":"119","author":"McDermott","year":"1969","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tube.2021.102091_bib24","first-page":"568","article-title":"Tubercle bacilli resistant to isoniazid: virulence and response to treatment with isoniazid in Guinea-pigs and mice","volume":"34","author":"Barnett","year":"1953","journal-title":"Br J Exp Pathol"},{"key":"10.1016\/j.tube.2021.102091_bib25","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1128\/jb.175.13.4255-4259.1993","article-title":"Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis","volume":"175","author":"Heym","year":"1993","journal-title":"J Bacteriol"},{"key":"10.1016\/j.tube.2021.102091_bib26","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2958.1993.tb01596.x","article-title":"Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations","volume":"8","author":"Zhang","year":"1993","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.tube.2021.102091_bib27","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1365-2958.1995.tb02276.x","article-title":"Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis","volume":"15","author":"Wilson","year":"1995","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.tube.2021.102091_bib28","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/358591a0","article-title":"The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis","volume":"358","author":"Zhang","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.tube.2021.102091_bib29","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1002\/(SICI)1521-3773(19990903)38:17<2588::AID-ANIE2588>3.0.CO;2-8","article-title":"Spontaneous formation of the bioactive form of the tuberculosis drug isoniazid","volume":"38","author":"Wilming","year":"1999","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.tube.2021.102091_bib30","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.1021\/ja00095a063","article-title":"Mechanistic studies of the oxidation of isoniazid by the catalase peroxidase from Mycobacterium tuberculosis","volume":"116","author":"Johnsson","year":"1994","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.tube.2021.102091_bib31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.8284673","article-title":"inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis","volume":"263","author":"Banerjee","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.tube.2021.102091_bib32","doi-asserted-by":"crossref","first-page":"8235","DOI":"10.1021\/bi00026a004","article-title":"Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis","volume":"34","author":"Quemard","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.tube.2021.102091_bib33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2958.1995.tb02238.x","article-title":"Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis","volume":"15","author":"Heym","year":"1995","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.tube.2021.102091_bib34","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1128\/AAC.00112-06","article-title":"Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis","volume":"50","author":"Hazbon","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2021.102091_bib35","doi-asserted-by":"crossref","first-page":"15356","DOI":"10.1038\/s41598-018-33370-6","article-title":"Understanding molecular consequences of putative drug resistant mutations in Mycobacterium tuberculosis","volume":"8","author":"Portelli","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.tube.2021.102091_bib36","article-title":"Differential sensitivity of mycobacteria to isoniazid is related to differences in KatG-mediated enzymatic activation of the drug","author":"Reingewertz","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2021.102091_bib37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12916-019-1487-2","article-title":"A landscape of genomic alterations at the root of a near-untreatable tuberculosis epidemic","volume":"18","author":"Klopper","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.tube.2021.102091_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119628","article-title":"Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review","volume":"10","author":"Seifert","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.tube.2021.102091_bib39","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nm1466","article-title":"Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid","volume":"12","author":"Vilcheze","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2021.102091_bib40","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1128\/AAC.00309-08","article-title":"Convergent evolutionary analysis identifies significant mutations in drug resistance targets of Mycobacterium tuberculosis","volume":"52","author":"Hazbon","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2021.102091_bib41","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.279.5347.98","article-title":"Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis","volume":"279","author":"Rozwarski","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.tube.2021.102091_bib42","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1080\/22221751.2020.1774425","article-title":"Emergence of multidrug-resistant Mycobacterium tuberculosis of the Beijing lineage in Portugal and Guinea-Bissau: a snapshot of moving clones by whole-genome sequencing","volume":"9","author":"Perdigao","year":"2020","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.tube.2021.102091_bib43","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1128\/iai.65.4.1395-1401.1997","article-title":"Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis","volume":"65","author":"Heym","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2021.102091_bib44","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/j.1365-2958.2004.04078.x","article-title":"Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst","volume":"52","author":"Ng","year":"2004","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.tube.2021.102091_bib45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1128\/IAI.67.1.74-79.1999","article-title":"Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro","volume":"67","author":"Manca","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2021.102091_bib46","first-page":"852","article-title":"Studies on isoniazid and tubercle bacilli. III. The isolation, drug-susceptibility, and catalase-testing of tubercle bacilli from isoniazid-treated patients","volume":"70","author":"Middlebrook","year":"1954","journal-title":"Am Rev Tubercul"},{"key":"10.1016\/j.tube.2021.102091_bib47","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1128\/IAI.70.9.4955-4960.2002","article-title":"Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans","volume":"70","author":"Pym","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2021.102091_bib48","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/jac\/dkp237","article-title":"Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance","volume":"64","author":"Bergval","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2021.102091_bib49","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1126\/science.272.5268.1641","article-title":"Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis","volume":"272","author":"Sherman","year":"1996","journal-title":"Science"},{"issue":"Pt 10","key":"10.1016\/j.tube.2021.102091_bib50","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1099\/00221287-144-10-2687","article-title":"Antisense RNA to ahpC, an oxidative stress defence gene involved in isoniazid resistance, indicates that AhpC of Mycobacterium bovis has virulence properties","volume":"144","author":"Wilson","year":"1998","journal-title":"Microbiology"},{"key":"10.1016\/j.tube.2021.102091_bib51","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1128\/jcm.35.3.719-723.1997","article-title":"Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level","volume":"35","author":"Telenti","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tube.2021.102091_bib52","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41588-017-0029-0","article-title":"Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis","volume":"50","author":"Coll","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.tube.2021.102091_bib53","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/317598","article-title":"Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in The Netherlands","volume":"182","author":"van Soolingen","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tube.2021.102091_bib54","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1371\/journal.ppat.0020061","article-title":"Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis","volume":"2","author":"Gagneux","year":"2006","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.tube.2021.102091_bib55","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/infdis\/jiv347","article-title":"Fitness costs of drug resistance mutations in multidrug-resistant Mycobacterium tuberculosis: a household-based case-control study","volume":"213","author":"Salvatore","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tube.2021.102091_bib56","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/003591577707000103","article-title":"Philip Ellman lecture. The modern management and therapy of pulmonary tuberculosis","volume":"70","author":"Fox","year":"1977","journal-title":"Proc Roy Soc Med"},{"key":"10.1016\/j.tube.2021.102091_bib57","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00907-19","article-title":"Automatic identification of individual rpoB gene mutations responsible for rifampin resistance in Mycobacterium tuberculosis by use of melting temperature signatures generated by the Xpert MTB\/RIF ultra assay","volume":"58","author":"Cao","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tube.2021.102091_bib58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1054\/tuld.1998.0002","article-title":"Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update","volume":"79","author":"Ramaswamy","year":"1998","journal-title":"Tuber Lung Dis"},{"key":"10.1016\/j.tube.2021.102091_bib59","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1128\/JCM.39.1.107-110.2001","article-title":"Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates","volume":"39","author":"Heep","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tube.2021.102091_bib60","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00431-007-0606-9","article-title":"Tuberculosis: drug resistance, fitness, and strategies for global control","volume":"167","author":"Bottger","year":"2008","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.tube.2021.102091_bib61","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmi.2016.09.006","article-title":"Consensus numbering system for the rifampicin resistance-associated rpoB gene mutations in pathogenic mycobacteria","volume":"23","author":"Andre","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.tube.2021.102091_bib62","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.resmic.2004.01.019","article-title":"Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution","volume":"155","author":"Maisnier-Patin","year":"2004","journal-title":"Res Microbiol"},{"key":"10.1016\/j.tube.2021.102091_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033507","article-title":"Estimating fitness by competition assays between drug susceptible and resistant Mycobacterium tuberculosis of predominant lineages in Mumbai, India","volume":"7","author":"Bhatter","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.tube.2021.102091_bib64","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4103\/ijmy.ijmy_97_19","article-title":"Competitive fitness of Mycobacterium tuberculosis in vitro","volume":"8","author":"Kodio","year":"2019","journal-title":"Int J Mycobacteriol"},{"key":"10.1016\/j.tube.2021.102091_bib65","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1073\/pnas.95.7.3949","article-title":"Virulence of antibiotic-resistant Salmonella typhimurium","volume":"95","author":"Bjorkman","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tube.2021.102091_bib66","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/genetics\/156.4.1471","article-title":"Compensatory evolution in rifampin-resistant Escherichia coli","volume":"156","author":"Reynolds","year":"2000","journal-title":"Genetics"},{"key":"10.1016\/j.tube.2021.102091_bib67","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1128\/AAC.43.8.1866","article-title":"Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis","volume":"43","author":"Billington","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2021.102091_bib68","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1128\/CMR.8.4.496","article-title":"Antimicrobial agent resistance in mycobacteria: molecular genetic insights","volume":"8","author":"Musser","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.tube.2021.102091_bib69","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1126\/science.1124410","article-title":"The competitive cost of antibiotic resistance in Mycobacterium tuberculosis","volume":"312","author":"Gagneux","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.tube.2021.102091_bib70","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng.1038","article-title":"Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes","volume":"44","author":"Comas","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.tube.2021.102091_bib71","doi-asserted-by":"crossref","first-page":"16072","DOI":"10.1038\/ncomms16072","article-title":"Structural insights into the mycobacteria transcription initiation complex from analysis of X-ray crystal structures","volume":"8","author":"Hubin","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.tube.2021.102091_bib72","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/jac\/dkt224","article-title":"Genetic characterization of compensatory evolution in strains carrying rpoB Ser531Leu, the rifampicin resistance mutation most frequently found in clinical isolates","volume":"68","author":"Brandis","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2021.102091_bib73","first-page":"643","article-title":"Mutational neighbourhood and mutation supply rate constrain adaptation in Pseudomonas aeruginosa","volume":"277","author":"Hall","year":"2010","journal-title":"Proc Biol Sci"},{"key":"10.1016\/j.tube.2021.102091_bib74","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0092-8674(00)81515-9","article-title":"Crystal structure of Thermus aquaticus core RNA polymerase at 3.3 A resolution","volume":"98","author":"Zhang","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.tube.2021.102091_bib75","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00164-18","article-title":"Source of the fitness defect in rifamycin-resistant Mycobacterium tuberculosis RNA polymerase and the mechanism of compensation by mutations in the beta' subunit","volume":"62","author":"Stefan","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2021.102091_bib76","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/mmi.13606","article-title":"Structural basis for rifamycin resistance of bacterial RNA polymerase by the three most clinically important RpoB mutations found in Mycobacterium tuberculosis","volume":"103","author":"Molodtsov","year":"2017","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.tube.2021.102091_bib77","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0092-8674(01)00286-0","article-title":"Structural mechanism for rifampicin inhibition of bacterial rna polymerase","volume":"104","author":"Campbell","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.tube.2021.102091_bib78","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/mmi.12520","article-title":"Fitness costs of rifampicin resistance in Mycobacterium tuberculosis are amplified under conditions of nutrient starvation and compensated by mutation in the beta' subunit of RNA polymerase","volume":"91","author":"Song","year":"2014","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.tube.2021.102091_bib79","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1128\/AAC.01541-12","article-title":"Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission","volume":"57","author":"de Vos","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2021.102091_bib80","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1186\/1471-2164-15-991","article-title":"Unraveling Mycobacterium tuberculosis genomic diversity and evolution in Lisbon, Portugal, a highly drug resistant setting","volume":"15","author":"Perdigao","year":"2014","journal-title":"BMC Genom"},{"key":"10.1016\/j.tube.2021.102091_bib81","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1002\/j.1460-2075.1984.tb02176.x","article-title":"Hyper-accurate ribosomes inhibit growth","volume":"3","author":"Ruusala","year":"1984","journal-title":"EMBO J"},{"key":"10.1016\/j.tube.2021.102091_bib82","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12864-016-2528-2","article-title":"Genomic and transcriptomic analysis of the streptomycin-dependent Mycobacterium tuberculosis strain 18b","volume":"17","author":"Benjak","year":"2016","journal-title":"BMC Genom"},{"key":"10.1016\/j.tube.2021.102091_bib83","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1128\/AAC.46.5.1204-1211.2002","article-title":"Fitness cost of chromosomal drug resistance-conferring mutations","volume":"46","author":"Sander","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2021.102091_bib84","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/3906","article-title":"Fitness of antibiotic-resistant microorganisms and compensatory mutations","volume":"4","author":"Bottger","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2021.102091_bib85","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1128\/AAC.40.11.2452","article-title":"Correlation of molecular resistance mechanisms and phenotypic resistance levels in streptomycin-resistant Mycobacterium tuberculosis","volume":"40","author":"Meier","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2021.102091_bib86","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1128\/AAC.38.2.228","article-title":"Genetic alterations in streptomycin-resistant Mycobacterium tuberculosis: mapping of mutations conferring resistance","volume":"38","author":"Meier","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2021.102091_bib87","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1365-2958.1993.tb01253.x","article-title":"Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot","volume":"9","author":"Finken","year":"1993","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.tube.2021.102091_bib88","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/ja.2012.5","article-title":"Deletion of gene encoding methyltransferase (gidB) confers high-level antimicrobial resistance in Salmonella","volume":"65","author":"Mikheil","year":"2012","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.tube.2021.102091_bib89","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1365-2958.2010.07218.x","article-title":"Directed mutagenesis of Mycobacterium smegmatis 16S rRNA to reconstruct the in vivo evolution of aminoglycoside resistance in Mycobacterium tuberculosis","volume":"77","author":"Shcherbakov","year":"2010","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.tube.2021.102091_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033275","article-title":"Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review","volume":"7","author":"Georghiou","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.tube.2021.102091_bib91","doi-asserted-by":"crossref","first-page":"20004","DOI":"10.1073\/pnas.0907925106","article-title":"Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis","volume":"106","author":"Zaunbrecher","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tube.2021.102091_bib92","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1261\/rna.057257.116","article-title":"Nonmutational compensation of the fitness cost of antibiotic resistance in mycobacteria by overexpression of tlyA rRNA methylase","volume":"22","author":"Freihofer","year":"2016","journal-title":"RNA"},{"key":"10.1016\/j.tube.2021.102091_bib93","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/femsre\/fux011","article-title":"Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives","volume":"41","author":"Gygli","year":"2017","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.tube.2021.102091_bib94","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/jac\/dks371","article-title":"From multidrug-resistant to extensively drug-resistant tuberculosis in Lisbon, Portugal: the stepwise mode of resistance acquisition","volume":"68","author":"Perdigao","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"10.1016\/j.tube.2021.102091_bib95","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1086\/428052","article-title":"Mechanisms of resistance to quinolones","volume":"41","author":"Jacoby","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tube.2021.102091_bib96","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MGM2-0009-2013","article-title":"The molecular genetics of fluoroquinolone resistance in Mycobacterium tuberculosis","volume":"2","author":"Mayer","year":"2014","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.tube.2021.102091_bib97","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/107662902760190617","article-title":"Evolutionary barriers to quinolone resistance in Streptococcus pneumoniae","volume":"8","author":"Gillespie","year":"2002","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.tube.2021.102091_bib98","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1073\/pnas.0408966102","article-title":"Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure","volume":"102","author":"Luo","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tube.2021.102091_bib99","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/emph\/eot003","article-title":"Epistasis between antibiotic resistance mutations drives the evolution of extensively drug-resistant tuberculosis","author":"Borrell","year":"2013","journal-title":"Evol Med Public Health"},{"key":"10.1016\/j.tube.2021.102091_bib100","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00224-20","article-title":"Fitness cost and compensatory evolution in levofloxacin-resistant Mycobacterium aurum","author":"Pi","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2021.102091_bib101","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jac\/dkx110","article-title":"Double mutation in DNA gyrase confers moxifloxacin resistance and decreased fitness of Mycobacterium smegmatis","volume":"72","author":"Luo","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2021.102091_bib102","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/molbev\/msz214","article-title":"The genetic background modulates the evolution of fluoroquinolone-resistance in Mycobacterium tuberculosis","volume":"37","author":"Castro","year":"2020","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.tube.2021.102091_bib103","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.2147\/IDR.S181124","article-title":"Drug-resistance profiling and transmission dynamics of multidrug-resistant Mycobacterium tuberculosis in Saudi Arabia revealed by whole genome sequencing","volume":"11","author":"Al-Ghafli","year":"2018","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.tube.2021.102091_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001880","article-title":"Evolution of extensively drug-resistant tuberculosis over four decades: whole genome sequencing and dating analysis of Mycobacterium tuberculosis isolates from KwaZulu-natal","volume":"12","author":"Cohen","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.tube.2021.102091_bib105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1473-3099(16)30418-2","article-title":"Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigation","volume":"17","author":"Yang","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tube.2021.102091_bib106","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/jac\/dkv345","article-title":"Evidence for the critical role of a secondary site rpoB mutation in the compensatory evolution and successful transmission of an MDR tuberculosis outbreak strain","volume":"71","author":"Meftahi","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2021.102091_bib107","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4046\/trd.2017.0042","article-title":"Patterns of rpoC mutations in drug-resistant Mycobacterium tuberculosis isolated from patients in South Korea","volume":"81","author":"Yun","year":"2018","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"10.1016\/j.tube.2021.102091_bib108","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1128\/AAC.02358-15","article-title":"Compensatory mutations of rifampin resistance are associated with transmission of multidrug-resistant Mycobacterium tuberculosis beijing genotype strains in China","volume":"60","author":"Li","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2021.102091_bib109","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41426-018-0101-6","article-title":"Have compensatory mutations facilitated the current epidemic of multidrug-resistant tuberculosis?","volume":"7","author":"Liu","year":"2018","journal-title":"Emerg Microb Infect"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147297922100041X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147297922100041X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:45:07Z","timestamp":1761468307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147297922100041X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":109,"alternative-id":["S147297922100041X"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2021.102091","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug resistance, fitness and compensatory mutations in Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2021.102091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102091"}}